Regeneron Pharmaceuticals Inc (REGN)

420.36
0.25 0.06
NASDAQ : Health Care
Prev Close 420.61
Open 419.61
Day Low/High 418.54 / 424.95
52 Wk Low/High 329.09 / 592.59
Volume 143.54K
Avg Volume 842.00K
Exchange NASDAQ
Shares Outstanding 105.29M
Market Cap 44.08B
EPS 6.20
P/E Ratio 65.31
Div & Yield N.A. (N.A)

Latest News

Regeneron Pharmaceuticals Becomes #39 Most Shorted Nasdaq 100 Component, Replacing JD.com

Regeneron Pharmaceuticals Becomes #39 Most Shorted Nasdaq 100 Component, Replacing JD.com

The most recent short interest data has been released for the 07/29/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AVG, CIT, CRNT, CX, EGL, FOE, GOOD, ISNS, KRNT, KTEC, LBY, LPX, MIXT, MPC, MTSI, NATR, NVTA, REGN, SSTK Downgrades: CBPX, DVA, FCFP, ITG, PBH, STN Initiations: CFMS, JCAP, LILA, LILAK, NIHD, PYPL Read on to get TheStreet Quant Ratings' detailed report:

CMCSA, IDXX, ZTS: Jim Cramer's Views

CMCSA, IDXX, ZTS: Jim Cramer's Views

Cramer shares his views on the winners and losers of this earnings season. Comcast, Idexx Laboratories and Zoetis are among the stocks discussed.

Unusual Social Activity Around Regeneron Pharmaceuticals (REGN) Today

Unusual Social Activity Around Regeneron Pharmaceuticals (REGN) Today

Trade-Ideas LLC identified Regeneron Pharmaceuticals (REGN) as an unusual social activity candidate

Cramer: Here's What to Embrace and What to Shun

Cramer: Here's What to Embrace and What to Shun

With enough of earnings season now under our belt, we check out the promising themes and the sectors to avoid.

Amgen and Regeneron Expanding Anti-Cancer Research

Amgen and Regeneron Expanding Anti-Cancer Research

The two Big Pharma giants are looking for new ways to drive growth through anti-cancer treatments.

Amgen, Regeneron Forge New, Separate Cancer Immunotherapy Pacts

Amgen, Regeneron Forge New, Separate Cancer Immunotherapy Pacts

The new deals signal a long-term commitment from two of the largest biotech companies to focus on cancer immunotherapy as a platform for future growth.

Regeneron And Adicet Bio Announce Strategic Collaboration To Discover And Develop Next-Generation Engineered Immune Cell Therapeutics

Regeneron And Adicet Bio Announce Strategic Collaboration To Discover And Develop Next-Generation Engineered Immune Cell Therapeutics

Regeneron and Adicet to pursue "off-the-shelf" cellular therapies in oncology

3 Stocks Boosting The Health Care Sector Higher

3 Stocks Boosting The Health Care Sector Higher

TheStreet highlights 3 stocks pushing the health care sector higher today.

Cramer: What Are You Thinking? It Should Be Long Term

Cramer: What Are You Thinking? It Should Be Long Term

That may be the best way to get through the notorious month of August.

Jim Cramer: I’m Looking at the Biotechs

Jim Cramer: I’m Looking at the Biotechs

Utilities and other high yielding sectors are reaching overbought levels, so investors may want to rotate into biotechs, says Jim Cramer.

Jim Cramer -- Celgene Igniting a Rally in Biotech

Jim Cramer -- Celgene Igniting a Rally in Biotech

The biotech sector was a great short throughout the year, but that trade appears to be over, Cramer said.

Regeneron Is Regenerating Lost Profits

Regeneron Is Regenerating Lost Profits

Investors should risk below $380 for now.

Regeneron Pharmaceuticals Becomes #185 Most Shorted S&P 500 Component, Replacing Republic Services

Regeneron Pharmaceuticals Becomes #185 Most Shorted S&P 500 Component, Replacing Republic Services

The most recent short interest data has been released for the 07/15/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

3 Drugs Stocks Pushing Industry Growth

3 Drugs Stocks Pushing Industry Growth

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week

Cramer is gearing up for the heaviest week of this earnings season, but he's also providing his game plan for helping you be a better investor.

3 Stocks Driving The Health Care Sector Higher

3 Stocks Driving The Health Care Sector Higher

TheStreet highlights 3 stocks pushing the health care sector higher today.

3 Stocks Pulling The Health Care Sector Downward

3 Stocks Pulling The Health Care Sector Downward

TheStreet highlights 3 stocks pushing the health care sector lower today.

Regeneron Pharmaceuticals Becomes #41 Most Shorted Nasdaq 100 Component, Replacing Vertex Pharmaceuticals

Regeneron Pharmaceuticals Becomes #41 Most Shorted Nasdaq 100 Component, Replacing Vertex Pharmaceuticals

The most recent short interest data has been released for the 06/30/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

5 Stocks Set to Soar on Bullish Earnings

5 Stocks Set to Soar on Bullish Earnings

These heavily shorted stocks could get squeezed much higher if they report positive earnings this wee.

Award-Winning Chef Elizabeth Falkner Reveals Her Struggle With Atopic Dermatitis To Highlight The Physical And Psychological Impact Of The Disease

Award-Winning Chef Elizabeth Falkner Reveals Her Struggle With Atopic Dermatitis To Highlight The Physical And Psychological Impact Of The Disease

Falkner has joined forces with Regeneron and Sanofi Genzyme in collaboration with leading dermatology organizations to educate Americans about a potentially serious, chronic inflammatory skin disease known as atopic dermatitis

CELG, REGN, DPZ: Jim Cramer's Views

CELG, REGN, DPZ: Jim Cramer's Views

Cramer shares his views on why something could be up in biotech, restaurants and retail. Celgene, Regeneron and Domino's are among the stocks discussed.

Cramer: Might Something Be Brewing in 3 Downtrodden Sectors?

Biotech, restaurants and retail have been left for dead but are showing signs of life today.

Biotech Stock Mailbag: Mid-Year Assessment, Where We Go From Here

Biotech Stock Mailbag: Mid-Year Assessment, Where We Go From Here

TheStreet's Adam Feuerstein answers reader questions about biotech stocks.

Regeneron Pharmaceuticals Becomes #209 Most Shorted S&P 500 Component, Replacing Assurant

Regeneron Pharmaceuticals Becomes #209 Most Shorted S&P 500 Component, Replacing Assurant

The most recent short interest data has been released for the 06/15/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Regeneron Tries to Recover From Lows

Prices pop today, but is this a reversal?